By Michael Susin
AstraZeneca said it has launched Evinova, a separate health-tech business to offer its knowledge of clinical-trial design and study delivery.
The Anglo-Swedish pharmaceutical giant on Monday said the business will deliver solutions at scale to trial sponsors, clinical-research organizations, care teams and patients. This includes…
Read the full article here